Cited by CrossRef (4)
- Clara Sortais, Stéphanie Cordeil, Estelle Bourbon, Maryam Idlhaj, Emmanuelle Ferrant, Violaine Safar, Camille Golfier, Anne Lazareth, Fadhela Bouafia-Sauvy, Jérémie Tordo, Hervé Ghesquières, Pierre Sesques, Emmanuel Bachy. Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas. Leukemia & Lymphoma 2023;64:707
- Chunting Zhu, Yi Zhao, Fang Yu, Weijia Huang, Wenjun Wu, Jingsong He, Zhen Cai, Donghua He. Tumor Flare Reaction in a Classic Hodgkin Lymphoma Patient Treated With Brentuximab Vedotin and Tislelizumab: A Case Report. Front. Immunol. 2022;12
- Mizuki Nishino. Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a “common language” for the new arena of cancer treatment. j. immunotherapy cancer 2016;4
- . Antineoplastics. Reactions Weekly 2015;1539:42